MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS

… clinical study of guselkumab in patients with moderate to severe hidradenitis suppurativa or HS, a chronic skin disease also known as acne inversa.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *